Drug Profile
NN 5501
Alternative Names: NN5501Latest Information Update: 16 Jan 2008
Price :
$50
*
At a glance
- Originator Novo Nordisk
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 1 diabetes mellitus; Type 2 diabetes mellitus
Most Recent Events
- 16 Jan 2008 Discontinued - Preclinical for Type-1 diabetes mellitus in Denmark (unspecified route)
- 16 Jan 2008 Discontinued - Preclinical for Type-2 diabetes mellitus in Denmark (unspecified route)
- 16 Apr 1999 New profile